DUBLIN, Calif., Oct. 22 SuperGen, Inc.(Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery anddevelopment of novel cancer therapies, today announced that James S. Manuso,Ph.D., President and Chief Executive Officer, is scheduled to present at the7th Annual Biotechnology Industry Organization (BIO) Investor Forum onWednesday, October 29, 2008, at the Palace Hotel in San Francisco.
SuperGen's presentation at the BIO Investor Forum is scheduled to begin at4:15 p.m. PDT (7:15 p.m. EDT). A live webcast of the presentation will beavailable on the investor relations section of the Company's Web site atwww.supergen.com. A webcast replay of the presentation will be availableshortly following the live event.
Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical companydedicated to the discovery and development of novel cancer therapies. SuperGenis developing a number of therapeutic anticancer products focused on kinaseand cell signaling inhibitors and DNA methyltransferase inhibitors. For moreinformation about SuperGen, please visit http://www.supergen.com.Contacts: SuperGen, Inc. Dorland Global Public Relations Timothy L. Enns Michael Beckerich (Media) SVP, Corporate Communications Tel: (212) 677-7632 & Business Development email@example.com Tel: (925) 560-0100 Email: firstname.lastname@example.org Mary M. Vegh Manager, Investor Relations Tel: (925) 560-2845 E-mail: email@example.com
SOURCE SuperGen, Inc.